TrialAntimicrobial agents and chemotherapy2019

First-in-Human Phase 1 Study To Assess Safety, Tolerability, and Pharmacokinetics of a Novel Antifungal Drug, VL-2397, in Healthy Adults.

Mammen P Mammen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.